Michelle Agnew, MD
Internal Medicine · Brookfield, WINPI 1720051550
Payments from drug & device makers
Across 44 payments — averaging $13.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$393
- Viiv Healthcare Company$62
- Insmed, Inc.$28
- Aimmune Therapeutics, Inc.$26
- Gilead$21
- Ferring Pharmaceuticals Inc.$17
- plus $28 from 2 others
What the payments were for
- Food & beverage$56298%
- Education$132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $393 |
| Viiv Healthcare Company | 3 | $62 |
| Insmed, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Gilead | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| Shionogi Inc | 1 | $13 |
How this compares
$575 in reported general payments places this provider in the 85th percentile of 1,411 internal medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErtapenemErtapenem Sodium | 11 | $5,527 |
| Daptomycin | 12 | $4,182 |
| CefuroximeCefuroxime Axetil | 63 | $3,158 |
| Doxycycline Monohydrate | 66 | $1,997 |
| Cephalexin | 44 | $1,285 |
| Vancomycin Hcl | 13 | $792 |
| Doxycycline Hyclate | 14 | $764 |
| Amoxicillin | 79 | $409 |
| Penicillin V Potassium | 25 | $331 |
| Cefadroxil | 27 | $330 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $168 |
| Nystatin | 11 | $125 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $93 |
| Atorvastatin Calcium | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Brookfield
- Nicholas SiebersMadison$47.3M
- Irene MirkinMiddleton$42.9M
- John BlanchardMadison$17.2M
- Carlos SanabriaWest Bend$12.9M
- Andrew KimWauwatosa$2.3M
- Jeremiah DeptaMilwaukee$2.2M
- Gilbert JenouriMilwaukee$2.2M
- Stephen FlachMadison$1.6M
- Aliaksandr TrusauGreen Bay$1.5M
- Samuel IdarragaWauwatosa$743K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.